STRO vs TT
Sutro Biopharma (STRO) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
STRO currently screens at market cap $470.8M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the STRO and TT stock pages for the full models.
Not investment advice.